	Compliance or Consequences Remember, the U.S. government set January 1, 2008, as the deadline for demonstrating full compliance with United States Pharmacopeia Chapter 797, “Pharmaceutical Compounding: Sterile Preparations.” Pharmacies inspected anytime after that date that fail to comply are risking exposure to patient lawsuits and/or potential loss of JCAHO accreditation.

	Complimentary Audit

USP 797 Testing and Compliance Solutions

Welcome to the Pharmacy Director’s single source for total USP 797 testing services that are professional, efficient, and cost-effective

Don’t have the experience necessary for compliance management? Or can’t afford to divert internal resources? Microtest is your ideal turnkey solution for USP 797 testing and compliance.

Microtest is the source for consulting services, laboratory testing, pharmaceutical manufacturing and regulatory response expertise, and environmental monitoring. We have everything that directors of sterile drug compounding pharmacies require both within hospitals and independent operations to respond to their urgent USP 797 compliance requirements.

Unlike other compliance vendors, Microtest avoids the pitfalls of a partial USP 797 testing solution: insufficient experience, inadequate capabilities, or poor follow-through.

We offer a full menu of must-have services:




	THE USP 797 COMPLIANCE CHALLENGE: Solutions for Compounding Pharmacies

	Download this free white paper now.

Compliance or Consequences

USP 797 Testing and Compliance Solutions